CMS certification 053303
Rady Children's Hospital - San Diego
3020 Childrens Way, San Diego, CA 92123
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Clinicians registered at this address
922 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 113 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Pediatrics | 203 |
| Clinical | 77 |
| Pediatric Emergency Medicine | 71 |
| Physical Therapist | 70 |
| Speech-Language Pathologist | 50 |
| Occupational Therapist | 44 |
| Dietitian, Registered | 38 |
| Pediatric Cardiology | 33 |
| Child & Adolescent Psychiatry | 27 |
| Pediatric Anesthesiology | 27 |
| Marriage & Family Therapist | 23 |
| Neonatal-Perinatal Medicine | 21 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $622,090
- 2020 $188,310
- 2021 $1M
- 2022 $280,502
- 2023 $1M
- 2024 $147,931
- 2025 $6.1M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $5.5M | 8 |
| Grants | $55,000 | 7 |
| Medical devices and supplies on long-term loan | $25,453 | 13 |
| Consulting fees | $24,700 | 1 |
| Space rental and facility fees | $24,000 | 5 |
| Charitable contributions | $2,600 | 2 |
| Debt forgiveness | $1,870 | 2 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $5.5M | 3 |
| Ionis Pharmaceuticals, Inc. | $208,302 | 13 |
| E.R. Squibb & Sons, L.L.C. | $140,572 | 2 |
| Abbvie INC. | $79,922 | 5 |
| Siemens Medical Solutions USA, Inc. | $42,500 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $38,327 | 2 |
| OrthoPediatrics Corp. | $24,700 | 1 |
| Stryker Corporation | $13,074 | 9 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| ION440-CS1 Ionis Pharmaceuticals, Inc. · NCT06430385 | $208,302 |
| A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (age 12 years to < 18 years) with Symptomatic Obs… E.R. Squibb & Sons, L.L.C. | $140,572 |
| A23-488;Venclexta;Blister Card: ABT-199 50mg Film-coated Tablet 1x8, 8 Tablets ABBVIE INC. | $65,090 |
| Pilot Study of Venetoclax in Combination with Conventional Chemotherapy in Pediatric Patients with Acute Myeloid Leukemia ABBVIE INC. | $14,683 |
| US observational study of DE oral pellets in patients <12 y Boehringer Ingelheim Pharmaceuticals, Inc. | $7,825 |
| THE UNITED STATES PEDIATRIC MULTICENTER PNEUMOCOCCAL SURVEILLANCEWI227301 PFIZER INC. | $6,800 |
| 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric a… National Marrow Donor Program | $825 |
| A single arm phase II trial in first line high risk HR pediatric and young adult patients with Bcell acute lymphoblastic leukemia ALL who are minimal… Novartis Pharmaceuticals Corporation | $230 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Rady Children's Hospital - San Diego
Does Rady Children's Hospital - San Diego have an emergency room?
No. CMS does not list emergency services at Rady Children's Hospital - San Diego.
Does Rady Children's Hospital - San Diego receive money from drug and device companies?
Drug and device makers reported $6.1M in payments to Rady Children's Hospital - San Diego for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.